- Home
- APLS vs RYN Comparison
APLS vs RYN Comparison
Compare APLS & RYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- RYN
- Stock Information
- Founded
- APLS 2009
- RYN 1926
- Country
- APLS United States
- RYN United States
- Employees
- APLS N/A
- RYN N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- RYN Real Estate Investment Trusts
- Sector
- APLS Health Care
- RYN Real Estate
- Exchange
- APLS Nasdaq
- RYN Nasdaq
- Market Cap
- APLS 4.0B
- RYN 4.5B
- IPO Year
- APLS 2017
- RYN N/A
- Fundamental
- Price
- APLS $30.13
- RYN $26.73
- Analyst Decision
- APLS Buy
- RYN Hold
- Analyst Count
- APLS 18
- RYN 3
- Target Price
- APLS $46.71
- RYN $33.00
- AVG Volume (30 Days)
- APLS 2.1M
- RYN 876.1K
- Earning Date
- APLS 02-25-2025
- RYN 02-05-2025
- Dividend Yield
- APLS N/A
- RYN 11.04%
- EPS Growth
- APLS N/A
- RYN 98.46
- EPS
- APLS N/A
- RYN 1.07
- Revenue
- APLS $715,216,000.00
- RYN $1,004,107,000.00
- Revenue This Year
- APLS $95.82
- RYN N/A
- Revenue Next Year
- APLS $12.02
- RYN N/A
- P/E Ratio
- APLS N/A
- RYN $24.95
- Revenue Growth
- APLS 162.10
- RYN 20.26
- 52 Week Low
- APLS $24.34
- RYN $24.88
- 52 Week High
- APLS $71.90
- RYN $35.29
- Technical
- Relative Strength Index (RSI)
- APLS 44.83
- RYN 46.83
- Support Level
- APLS $27.61
- RYN $24.88
- Resistance Level
- APLS $30.13
- RYN $26.62
- Average True Range (ATR)
- APLS 1.50
- RYN 0.59
- MACD
- APLS -0.35
- RYN 0.25
- Stochastic Oscillator
- APLS 33.82
- RYN 91.58
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About RYN Rayonier Inc. REIT
Rayonier owns and manages over 2 million acres of timberland in the United States. It is one the largest private landowners in North America. The firm also owns timberland in New Zealand. Rayonier is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities.